234
Views
10
CrossRef citations to date
0
Altmetric
Research Article

Vesicle-to-cytosol transport of disulfide-linked cargo mediated by an amphipathic cell-penetrating peptide

, &
Pages 793-800 | Received 31 May 2012, Accepted 07 Aug 2012, Published online: 20 Sep 2012

References

  • Aubry S, Burlina F, Dupont E, Delaroche D, Joliot A, Lavielle S, Chassaing G, Sagan S. (2009). Cell-surface thiols affect cell entry of disulfide-conjugated peptides. FASEB J, 23, 2956–2967.
  • Barnes M, Shen WC. (2009). Disulfide and thioether linked cytochrome c-oligoarginine conjugates in HeLa cells. Int J Pharm, 369, 79–84.
  • Collier RJ. (2001). Understanding the mode of action of diphtheria toxin: a perspective on progress during the 20th century. Toxicon, 39, 1793–1803.
  • Deshayes S, Morris MC, Divita G, Heitz F. (2005). Cell-penetrating peptides: tools for intracellular delivery of therapeutics. Cell Mol Life Sci, 62, 1839–1849.
  • Eiríksdóttir E, Konate K, Langel U, Divita G, Deshayes S. (2010). Secondary structure of cell-penetrating peptides controls membrane interaction and insertion. Biochim Biophys Acta, 1798, 1119–1128.
  • Endoh T, Ohtsuki T. (2009). Cellular siRNA delivery using cell-penetrating peptides modifed for endosomal escape. Adv Drug Deliv Rev, 61, 704–709.
  • Fattal E, Nir S, Parente RA, Szoka FC Jr. (1994). Pore-forming peptides induce rapid phospholipid flip-flop in membranes. Biochemistry, 33, 6721–6731.
  • Feener EP, Shen WC, Ryser HJ. (1990). Cleavage of disulfide bonds in endocytosed macromolecules. A processing not associated with lysosomes or endosomes. J Biol Chem, 265, 18780–18785.
  • Fei L, Ren L, Zaro JL, Shen WC. (2011). The influence of net charge and charge distribution on cellular uptake and cytosolic localization of arginine-rich peptides. J Drug Target, 19, 675–680.
  • Huffman HA, Sadeghi M, Seemuller E, Baumeister W, Dunn MF. (2003). Proteasome-Cyt c interactions: a model system for investigation of proteasome host-guest interactions. Biochem, 42, 8679–8686.
  • Jiang X, Wang X. (2004). Cytochrome C-mediated apoptosis. Annu Rev Biochem, 73, 87–106.
  • Jiao CY, Delaroche D, Burlina F, Alves ID, Chassaing G, Sagan S. (2009). Translocation and endocytosis for cell-penetrating peptide internalization. J Biol Chem, 284, 33957–33965.
  • Li F, Srinivasan A, Wang Y, Armstrong RC, Tomaselli KJ, Fritz LC. (1997). Cell-specific induction of apoptosis by microinjection of cytochrome c. J Biol Chem, 272, 30299–30305.
  • Lundberg P, Langel U. (2003). A brief introduction to cell-penetrating peptides. J Mol Recognit, 16, 227–233.
  • Kenien R, Zaro JL, Shen WC. (2012). MAP-mediated nuclear delivery of a cargo protein. J Drug Target, 20, 329–337.
  • Maiolo JR, Ferrer M, Ottinger EA. (2005). Effects of cargo molecules on the cellular uptake of arginine-rich cell-penetrating peptides. Biochim Biophys Acta, 1712, 161–172.
  • Mandel R, Ryser HJ, Ghani F, Wu M, Peak D. (1993). Inhibition of a reductive function of the plasma membrane by bacitracin and antibodies against protein disulfide-isomerase. Proc Natl Acad Sci USA, 90, 4112–4116.
  • Martin I, Teixido M, Giralt E. (2010).Building cell selectivity into CPP-mediated strategies. Pharmaceuticals, 3, 1456–1490.
  • Nicol F, Nir S, Szoka FC Jr. (2000). Effect of phospholipid composition on an amphipathic peptide-mediated pore formation in bilayer vesicles. Biophys J, 78, 818–829.
  • Patel LN, Zaro JL, Shen WC. (2007). Cell penetrating peptides: intracellular pathways and pharmaceutical perspectives. Pharm Res, 24, 1977–1992.
  • Rajendran L, Knölker HJ, Simons K. (2010). Subcellular targeting strategies for drug design and delivery. Nat Rev Drug Discov, 9, 29–42.
  • Rothbard JB, Jessop TC, Wender PA. (2005). Adaptive translocation: the role of hydrogen bonding and membrane potential in the uptake of guanidinium-rich transporters into cells. Adv Drug Deliv Rev, 57, 495–504.
  • Ryser HJ, Mandel R, Ghani F. (1991). Cell surface sulfhydryls are required for the cytotoxicity of diphtheria toxin but not of ricin in Chinese hamster ovary cells. J Biol Chem, 266, 18439–18442.
  • Säälik P, Niinep A, Pae J, Hansen M, Lubenets D, Langel Ü, Pooga M. (2011). Penetration without cells: membrane translocation of cell-penetrating peptides in the model giant plasma membrane vesicles. J Control Release, 153, 117–125.
  • Saito G, Swanson JA, Lee KD. (2003). Drug delivery strategy utilizing conjugation via reversible disulfide linkages: role and site of cellular reducing activities. Adv Drug Deliv Rev, 55, 199–215.
  • Scheller A, Oehlke J, Wiesner B, Dathe M, Krause E, Beyermann M, Melzig M, Bienert M. (1999). Structural requirements for cellular uptake of alpha-helical amphipathic peptides. J Pept Sci, 5, 185–194.
  • Schmidt N, Mishra A, Lai GH, Wong GCL. (2010). Arginine Rich Cell Penetrating Peptides. FEBS Lett, 584, 1806–1813.
  • Sonoda S, Schlamowitz M. (1970). Studies of 125I trace labeling of immunoglobulin G by chloramine-T. Immunochemistry, 7, 885–898.
  • Torchilin V. (2009). Multifunctional and stimuli-sensitive pharmaceutical nanocarriers. Eur J Pharm Biopharm, 71, 431–444.
  • Tunnemann G, Martin RM, Haupt S, Patsch C, Edenhofer F, Cardoso MC. (2006). Cargo-dependent mode of uptake and bioavailability of TAT-containing proteins and peptides in living cells. FASEB J, 20, 1775–1784.
  • Walker JM. (2002). SDS polyacyrlamide gel electrophoresis of proteins. In: Walker JM, ed. The Protein Protocols Handbook. Totowa, New Jersey: Humana Press Inc., 61–72.
  • Wender PA, Galliher WC, Goun EA, Jones LR, Pillow TH. (2008). The design of guanidinium-rich transporters and their internalization mechanisms. Adv Drug Deliv Rev, 60, 452–472.
  • Wyman TB, Nicol F, Zelphati O, Scaria PV, Plank C, Szoka F. (1997) Design, Synthesis and Characterization of a Cationic Peptide that Binds to Nucleaic Acids and Permeabilizes Bilayers. Biochem, 36, 3008–3017.
  • Yamaizumi M, Mekada E, Uchida T, Okada Y. (1978). One molecule of diphtheria toxin fragment A introduced into a cell can kill the cell. Cell, 15, 245–250.
  • You BR, Park WH. (2011). The enhancement of propyl gallate-induced apoptosis in HeLa cells by a proteasome inhibitor MG132. Oncol Rep, 25, 871–877.
  • Zaro JL, Shen WC. (2003). Quantitative comparison of membrane transduction and endocytosis of oligopeptides. Biochem Biophys Res Commun, 307, 241–247.
  • Zaro JL, Shen WC. (2005). Cytosolic delivery of a p16-peptide oligoarginine conjugate for inhibiting proliferation of MCF7 cells. J Control Release, 108, 409–417.
  • Zaro JL, Vekich JE, Tran T, Shen WC. (2009). Nuclear localization of cell-penetrating peptides is dependent on endocytosis rather than cytosolic delivery in CHO cells. Mol Pharm, 6, 337–344.
  • Zhang L, Hu JJ, Gong F. (2011). MG132 inhibition of proteasome blocks apoptosis induced by severe DNA damage. Cell Cycle, 10, 3515–3518.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.